OptimizeRx (OPRX) Shares Outstanding (2010 - 2026)

OptimizeRx's Shares Outstanding history runs 17 years deep, the most recent figure standing at $20.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 1.35% year-over-year to $20.5 million; the TTM figure through Mar 2026 stood at $20.5 million (up 1.35% YoY), while the FY2025 annual figure was $18.8 million, down 7.11% from the prior year.
• Shares Outstanding came in at $20.5 million for Q1 2026 at OptimizeRx, up from $18.8 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $20.3 million in Q3 2025 to a low of -$1.7 million in Q2 2024.
• A 5-year average of $16.8 million and a median of $18.8 million in 2025 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding jumped 664189.72% in 2022 and slumped 13432.77% in 2023, its largest moves.
• OptimizeRx's Shares Outstanding stood at $18.3 million in 2022, then climbed by 8.81% to $19.9 million in 2023, then increased by 1.48% to $20.2 million in 2024, then slipped by 7.11% to $18.8 million in 2025, then climbed by 9.31% to $20.5 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $20.5 million, $18.8 million, and $18.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison